During the past decade, Olathe Medical Center conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 18 clinical trials were completed, i.e. on average, 105.9% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 15 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Olathe Medical Center" #1 sponsor was "SWOG Cancer Research Network" with 16 trials, followed by "Alliance for Clinical Trials in Oncology" with 2 trials sponsored, "National Cancer Institute (NCI)" with 2 trials sponsored, "Spiration, Inc." with 2 trials sponsored and "Alexion" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Olathe Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 19 trials as a collaborator, "Astellas Pharma US, Inc." with 1 trials as a collaborator, "Biologics, Inc." with 1 trials as a collaborator, "Canadian Cancer Trials Group" with 1 trials as a collaborator and "Eastern Cooperative Oncology Group" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Olathe Medical Center" are "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Breast Cancer" (2 trials), "Colorectal Cancer" (2 trials) and "ATM Gene Mutation" (1 trials). Many other conditions were trialed in "Olathe Medical Center" in a lesser frequency.

Most popular intervention types in "Olathe Medical Center" are "Drug" (22 trials), "Other" (14 trials), "Biological" (9 trials), "Device" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (11 trials), "Docetaxel" (4 trials), "Durvalumab" (3 trials), "Capecitabine" (2 trials) and "Cisplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Olathe Medical Center" are 25 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Olathe Medical Center". undefined are not yet recruiting, undefined are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Olathe Medical Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Olathe Medical Center, 1 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".

Olathe Medical Center has several departments that took part in Clinical trials: "Olathe Health Cancer Center" - 124 trials, "Consultants in Pulmonary Medicine" - 3 trials, "Radiation Oncology Center of Olathe" - 2 trials